Historical record - last NADAC effective date: 2/22/2017
Product Information
VENLAFAXINE HCL 37.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2564 per EA under NDC 65862040501. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Apr 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862040501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090555FDA Approved
4/7/2010
TE Code
AB
On Market Since
4/7/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 37.5 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2564 per EA |
|---|---|
| All-time high | $0.4135 (Jan 13, 2016) |
| All-time low | $0.2360 (Jan 18, 2017) |
| Median price | $0.3039 |
| Average price | $0.3047 |
| Largest weekly change | +26.5% (Dec 23, 2015) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-15.6%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Venlafaxine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 37.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2564 per EA (NDC 65862040501), effective Feb 22, 2017.
How has the price of VENLAFAXINE HCL 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has declined 15.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 37.5 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 37.5 MG TABLET has ranged from a low of $0.2360 (Jan 18, 2017) to a high of $0.4135 (Jan 13, 2016), with a median of $0.3039 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 37.5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0714 per EA — about 72% below VENLAFAXINE HCL 37.5 MG TABLET.
Who manufactures VENLAFAXINE HCL 37.5 MG TABLET?
VENLAFAXINE HCL 37.5 MG TABLET (NDC 65862040501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.